TrialAnnals of clinical and translational neurology2021

Clinical trial of raltegravir, an integrase inhibitor, in HAM/TSP.

Yoshimi Enose-Akahata et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.